# DESCRIPTION

## FIELD OF THE INVENTION

- introduce engineered polypeptides

## BACKGROUND OF THE INVENTION

- motivate biologics
- describe antibody effector function
- summarize Fc receptor types
- explain Fc receptor binding
- discuss prior art Fc region variants
- identify need for silent Fc region

## SUMMARY OF THE INVENTION

- introduce Fc variants with reduced affinity
- describe L234A, L235A, and P329A substitutions
- summarize properties of LALA-PA polypeptide
- introduce LALE-PG polypeptide

## DETAILED DESCRIPTION OF THE INVENTION

- define technical terms
- explain numbering of amino acid residues
- describe aspects and embodiments of the disclosure
- introduce variant Fc domain and its advantages
- define Fc region and its components
- explain effector function and its types
- describe Fc gamma receptor and FcRn
- motivate Fc variants with reduced effector function
- describe ADCC and CDC assays
- introduce LALA-PA and LALE-PG Fc variants
- summarize results of testing FcR binding and developability
- describe advantages of LALA-PA and LALE-PG substitutions
- define Fc fusion protein
- define antibody structures
- describe monoclonal antibody
- define antigen-binding fragment
- describe multispecific antibody
- define epitope
- describe antibody structure and function
- define developable
- describe methods to ascertain developability
- provide examples to illustrate the invention

## EXAMPLES

### Example 1: Antibodies

- generate CD3 antibody variants

### Example 2: THP-1 Cell Binding and C1q Binding to Antibodies

- test THP-1 cell binding
- test C1q binding

### Example 3: FcγR Binding by Antibodies

- measure FcγR binding by SPR
- analyze binding responses

### Example 4: Developability Assays

- prepare polyspecific reactivity reagent
- perform polyreactivity assay
- measure retention time by HIC
- analyze self-association by AC-SINS
- analyze aggregation by ProA SEC
- perform pH stress analysis
- measure titer
- measure melting temperature by DSF
- measure CD3 affinity by ForteBio
- summarize developability results

### Example 5: ADCC Activity Assay

- assess ADCC activity

### Example 6: Complement Activity Assay

- assess CDC activity

